Results 41 to 50 of about 9,870,305 (401)

The Clinical Pharmacology and Therapeutic Evaluation of Non-Steroidal Anti-Inflammatory Drugs in Adult Horses

open access: yesAnimals, 2023
This review firstly examines the underlying pathophysiology of pain and inflammation associated with orthopedic disease and endotoxemia. Then, it reviews the clinical pharmacology (pharmacokinetics and pharmacodynamics) of both conventional and non ...
Melissa A. Mercer   +2 more
doaj   +1 more source

Pharmacokinetics and Clinical Pharmacology of Monoclonal Antibodies in Pediatric Patients

open access: yesPediatric Drugs, 2020
Monoclonal antibodies (mAbs) and their derivatives are increasingly used in pediatric pharmacotherapy, and the number of antibody-based drug products with approved pediatric indications is continuously growing.
Zaid H. Temrikar   +2 more
semanticscholar   +1 more source

Pharmacogenetics : the science of predictive clinical pharmacology [PDF]

open access: yes, 2014
The study of pharmacogenetics has expanded from what were initially casual family-based clinical drug response observations, to a fully-fledged science with direct therapeutic applications, all within a time-span of less than 60 years. A wide spectrum of
Fenech, Anthony G., Grech, Godfrey
core   +1 more source

Effect of severe renal impairment on pharmacokinetics, safety, and tolerability of lemborexant

open access: yesPharmacology Research & Perspectives, 2021
The primary aim of this study was to examine the effect of severe renal impairment (SRI) on the pharmacokinetics of lemborexant, a dual orexin receptor antagonist indicated for the treatment of insomnia.
Ishani Landry   +6 more
doaj   +1 more source

Strong Association between Inotrope Administration and Intraventricular Hemorrhage, Gestational Age, and the Use of Fentanyl in Very Low Gestational Age Infants: A Retrospective Study

open access: yesChildren, 2023
This was a single center, retrospective cohort study designed to evaluate the association between the administration of inotropes to hypotensive very low gestational age infants (VLGAI) and prenatal and neonatal risk factors.
Theodora Stathopoulou   +5 more
doaj   +1 more source

Integrating pharmacology and clinical pharmacology [PDF]

open access: yesBritish Journal of Clinical Pharmacology, 2011
I here reaffirm some of the points that I made in the manifesto for UK clinical pharmacology [1], in response to letters from others. Much of what I wrote in the manifesto addresses points that correspondents have made, but as some of the important points may not have been clear on a first reading, I shall reiterate them and add clarifications. I am
openaire   +3 more sources

Traditional Chinese Medicine and Clinical Pharmacology

open access: yesDrug Discovery and Evaluation: Methods in Clinical Pharmacology, 2020
Traditional Chinese Medicine (TCM) represents thousands of years in treatment protocols for health, healing, and longevity and has evolved into a complex healthcare system.
A. Marshall
semanticscholar   +1 more source

Medication Utilisation Program, Quality Improvement and Research Pharmacist—Implementation Strategies and Preliminary Findings

open access: yesPharmacy, 2021
Judicious use of medicines that considers evidence-based practice, together with cost-effectiveness, is a priority for all health care organisations. We describe an initiative to lead a Medication Utilisation Program, incorporating medication quality ...
Karen Whitfield   +3 more
doaj   +1 more source

Neonatal clinical pharmacology [PDF]

open access: yesPediatric Anesthesia, 2013
SummaryEffective and safe drug administration in neonates should be based on integrated knowledge on the evolving physiological characteristics of the infant who will receive the drug and the pharmacokinetics (PK) and pharmacodynamics (PD) of a given drug.
Karel Allegaert   +4 more
openaire   +3 more sources

On the Clinical Pharmacology of Reactive Oxygen Species

open access: yesPharmacological Reviews, 2020
Reactive oxygen species (ROS) have been correlated with almost every human disease. Yet clinical exploitation of these hypotheses by pharmacological modulation of ROS has been scarce to nonexistent. Are ROS, thus, irrelevant for disease? No.
A. I. Casas   +15 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy